Stonepine Capital, L.P.'s Net Worth

Stonepine Capital, L.P.'s net worth is estimated to be at least $5,481,166.98 as of 11/09/2024. CoreStreet's estimation of Stonepine Capital, L.P.'s net worth is based on their sale of stock and current holding of stock.

Stonepine Capital, L.P. is Major Shareholder at Milestone Pharmaceuticals Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 100,000 units of MIST stock on 10/11/2019. Their biggest sale was on 12/26/2018 when they sold 500,000 units of Apollo Endosurgery Inc stock for $1,500,000.00. They typically trade 3 times per year.

Total value of insider buys:
  • $3,231,166.98
Total value of insider sells:
  • $2,250,000.00
Most recent insider trade:
  • Oct. 11, 2019

Stonepine Capital, L.P.'s Insider Trading History

Milestone Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Oct. 11, 2019
Major Shareholder100,000$0.63Buy$63,000.00
Apollo Endosurgery IncTitleAmountPriceTypeTotal Value
Dec. 27, 2018
Major Shareholder250,000$3.00Sell$750,000.00
Dec. 26, 2018
Major Shareholder500,000$3.00Sell$1,500,000.00
Nov. 21, 2018
Major Shareholder57,430$3.41Buy$195,836.30
Nov. 19, 2018
Major Shareholder54,200$3.40Buy$184,280.00
Nov. 2, 2018
Major Shareholder300,000$5.00Buy$1,500,000.00
Jan. 3, 2018
Major Shareholder22,845$5.71Buy$130,444.95
Dec. 29, 2017
Major Shareholder5,163$5.56Buy$28,706.28
Dec. 26, 2017
Major Shareholder5,287$5.00Buy$26,435.00
Dec. 22, 2017
Major Shareholder185,157$4.85Buy$898,011.45
Dec. 20, 2017
Major Shareholder45,434$4.50Buy$204,453.00